Filing Details
- Accession Number:
- 0000908662-14-000273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-04 16:52:47
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-04
- Accepted Time:
- 2014-11-04 16:52:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1177648 | Enanta Pharmaceuticals Inc | ENTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571211 | R. Jay Luly | C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-11-03 | 11,777 | $42.38 | 532,561 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-03 | 3,223 | $43.05 | 529,338 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2013 to provide liquidity for tax payments due on account of options exercised in 2014.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.8400 to $42.8300, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.8400 to $43.5300, inclusive.
Billionaire Hedge Funds
